US 12377090
Methods for treating neutropenia
granted A61KA61K31/4709A61K38/193
Quick answer
US patent 12377090 (Methods for treating neutropenia) held by X4 Pharmaceuticals, Inc. expires Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- X4 Pharmaceuticals, Inc.
- Grant date
- Tue Aug 05 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 28
- CPC classes
- A61K, A61K31/4709, A61K38/193, A61K9/0019, A61P